HER-2/neu Overexpression as a Predictor for the Transition from In situ to Invasive Breast Cancer

Por Roses, Robert E., Paulson, E. Carter, Sharma, Anupama, Schueller, Jeanne E., Nisenbaum, Harvey, Weinstein, Susan, Fox, Kevin R., Zhang, Paul J., Czerniecki, Brian J.
Publicado em 2009

The Significance of HER-2/neu Receptor Positivity and Immunophenotype in Ductal Carcinoma In-Situ with Early Invasive Disease

Por Harada, Shuko, Mick, Rosemarie, Roses, Robert E., Graves, Holley, Niu, Huilin, Sharma, Anupama, Schueller, Jeanne E., Nisenbaum, Harvey, Czerniecki, Brian J., Zhang, Paul J
Publicado em 2011

Does Use of a PACS Increase the Number of Images Per Study? A Case Study in Ultrasound

Por Horii, Steven, Nisenbaum, Harvey, Fam, James, Coleman, Beverly, Rowling, Susan, Langer, Jill, Jacobs, Jill, Arger, Peter, Pinheiro, Lisa, Klein, Wendy, Reber, Michele, Lyoob, Christopher
Publicado em 2002

Asymptomatic Changes in Cardiac Function Can Occur in DCIS Patients Following Treatment with HER-2/neu Pulsed Dendritic Cell Vaccines

Por Bahl, Susan, Roses, Robert, Sharma, Anupama, Koldovsky, Ursula, Xu, Shuwen, Weinstein, Susan, Nisenbaum, Harvey, Fox, Kevin, Pasha, Theresa, Zhang, Paul, Araujo, Louis, Carver, Joseph, Czerniecki, Brian J
Publicado em 2009

A novel dendritic cell-based immunization approach for the induction of durable Th1-polarized anti-HER-2/neu responses in women with early breast cancer

Por Koski, Gary K., Koldovsky, Ursula, Xu, Shuwen, Mick, Rosemarie, Sharma, Anupama, Fitzpatrick, Elizabeth, Weinstein, Susan, Nisenbaum, Harvey, Levine, Bruce L, Fox, Kevin, Zhang, Paul, Czerniecki, Brian J
Publicado em 2012

HER-2 Pulsed Dendritic Cell Vaccine Can Eliminate HER-2 Expression and Impact DCIS

Por Sharma, Anupama, Koldovsky, Ursula, Xu, Shuwen, Mick, Rosemarie, Roses, Robert, Fitzpatrick, Elizabeth, Weinstein, Susan, Nisenbaum, Harvey, Levine, Bruce L, Fox, Kevin, Zhang, Paul, Koski, Gary, Czerniecki, Brian J
Publicado em 2012

A Dendritic Cell Vaccine Pulsed with Autologous Hypochlorous Acid-Oxidized Ovarian Cancer Lysate Primes Effective Broad Antitumor Immunity: From Bench to Bedside

Por Chiang, Cheryl Lai-Lai, Kandalaft, Lana E., Tanyi, Janos, Hagemann, Andrea R., Motz, Gregory T., Svoronos, Nikolaos, Montone, Kathleen, Mantia-Smaldone, Gina M., Nisenbaum, Harvey L., Levine, Bruce L., Kalos, Michael, Czerniecki, Brian J., Torigian, Drew A., Powell, Daniel J., Mick, Rosemarie, Smith, Lori, Coukos, George
Publicado em 2013